Loews Corp Boosts Elevance Health Stake by 107.5%

Institutional investor Loews Corp significantly increased its holdings in health insurance provider Elevance Health, Inc. in the third quarter.

Mar. 17, 2026 at 10:07am

Got story updates? Submit your updates here. ›

According to a recent 13F filing, Loews Corp raised its stake in Elevance Health, Inc. (NYSE:ELV) by 107.5% in the third quarter, now owning 110,000 shares of the company's stock. Elevance Health, formerly known as Anthem, Inc., is a major U.S. health benefits provider offering medical and specialty health plans for individuals, employers, and government programs.

Why it matters

Elevance Health is one of the largest health insurance companies in the United States, and institutional investor activity in its stock can signal broader market trends and investor sentiment around the healthcare sector. Loews Corp's significant increase in its Elevance Health holdings suggests the investment firm sees long-term value in the company's business model and growth prospects.

The details

Loews Corp's 13F filing revealed that the firm added 57,000 shares of Elevance Health during the third quarter, bringing its total holdings to 110,000 shares. This 107.5% increase makes Elevance Health Loews Corp's 3rd largest portfolio holding, accounting for about 0.3% of the firm's total investments.

  • Loews Corp increased its Elevance Health stake in the third quarter of 2026.

The players

Loews Corp

A diversified holding company that owns and operates subsidiaries in the insurance, energy, hospitality, and packaging industries.

Elevance Health, Inc.

A major U.S. health benefits company that provides medical and specialty health plans for individuals, employers, and government programs.

Got photos? Submit your photos here. ›

The takeaway

Loews Corp's substantial increase in its Elevance Health holdings suggests the investment firm sees strong long-term potential in the health insurance provider's business model and growth prospects, which could signal broader optimism around the healthcare sector among institutional investors.